Browse > Article

Characteristics of Brain Perfusion in Patients of Parkinson's Disease  

Jeong, Young-Jin (Departments of Nuclear Medicine, Dong-A University College of Medicine)
Park, Min-Jung (Departments of Neurology, Dong-A University College of Medicine)
Kim, Jae-Woo (Departments of Neurology, Dong-A University College of Medicine)
Kang, Do-Young (Departments of Nuclear Medicine, Dong-A University College of Medicine)
Publication Information
Nuclear Medicine and Molecular Imaging / v.42, no.1, 2008 , pp. 17-28 More about this Journal
Abstract
Purpose: It was well known that cerebral blood perfusion is normal or diffusely decreased in the majority of patients with Parkinson's disease (PD). Actually we interpreted brain perfusion SPECT images of PD patients in the clinical situation, we observed various cerebral perfusion patterns in patients with PD. So we performed brain perfusion SPECT to know the brain perfusion patterns of PD patients and the difference of perfusion patterns according to the sex and the age. Also we classified PD patients into small groups based on the brain perfusion pattern. Methods and Materials: Two hundred nineteen patients (M: 70, F: 149, mean age: $62.9{\pm}6.9$ y/o) who were diagnosed as PD without dementia clinically and 55 patients (M:15, F:40, mean age: $61.4{\pm}9.2$ y/o) as normal controls who had no past illness history were performed $^{99m}Tc$-HMP AO brain perfusion SPECT and neuropsychological test. Results: At first, we compared all patients with PD and normal controls. Brain perfusion in left inferior frontal gyrus, left insula, left transverse temporal gyrus, left inferior parietal lobule, left superior parietal lobule, right precuneus, right caudate tail were lower in patients with PD than normal controls. Secondly, we compared male and female patients with PD and normal controls, respectively. Brain perfusion SPECT showed more decreased cerebral perfusion in left hemisphere than right side in both male and female patients compared to normal controls. And there was larger hypoperfusion area in female patients compared with male. Thirdly, we classified patients with PD and normal controls into 4 groups according to the age and compared brain perfusion respectively. In patient below fifties, brain perfusion in both occipitoparietal and left temporal lobe were lower in PD group. As the patients with PD grew older, hypoperfusion area were shown in both frontal, temporal and limbic lobes. Fourthly, We were able to divide patients into small groups based on cerebral perfusion pattern. There was normal cerebral blood perfusion in 32 (14.7%) of 219 patients with PD, decreased perfusion on the frontal lobe in 45 patients (20.6%), the temporal lobe in 39 patients (17.4%), the parietal lobe in 39 patients (17.9%), the occipital lobe in 40 patients (18.3%), diffuse area in 14 patients (6.4%) and unclassified in 10 patients (4.6%). Fifthly, we compared the results of the neuropsychological test and cerebral perfusion pattern. There was no correlation between two tests except visuospatial function. Conclusion: Various perfusion state were found in patients with PD according to the age and sex. Also we were able to classify perfusion state into several groups and compare the neuropsychological test with cerebral perfusion.
Keywords
brain perfusion SPECT; $^{99m}Tc$-HMPAO; Parkinson's disease; statistical parametric mapping; neuropsychological test;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006;5:75-86   DOI   ScienceOn
2 Ceballos-Baumann AO. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT. J Neurol 2003;250:15-23   DOI   ScienceOn
3 Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 2005;11:227-32   DOI   ScienceOn
4 Dujardin K, Defebvre L, Duhamel A, Lecouffe P, Rogelet P, Steinling M, et al. Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol 2004;251:1383-92   DOI
5 Defebvre LJ, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999;40:956-62
6 Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-22   DOI
7 Bosman T, Van Laere K, Santens P. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 2003;30:16-24   DOI
8 Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708-15   DOI   ScienceOn
9 Globus M, Mildworf B, Melamed E. Cerebral blood flow and cognitive impairment in Parkinson's disease. Neurology 1985;35:1135-9   DOI
10 Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:45-6   DOI
11 Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease. J Neurol Sci 2006;241:67-72   DOI   ScienceOn
12 Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309-19   DOI   ScienceOn
13 Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40:1583-9
14 Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, et al. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 2002;17:1265-70   DOI   ScienceOn
15 Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDGPET study. Brain 2000;123:340-52   DOI   ScienceOn
16 Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.; 2003
17 Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998;121:949-65   DOI   ScienceOn
18 Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, et al. 99mTc-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab 1988;1:101-8
19 Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1998;38:1402-6
20 Bissessur S, Tissingh G, Wolters EC, Scheltens P. rCBF SPECT in Parkinson's disease patients with mental dysfunction. J Neural Transm Suppl 1997;50:25-30
21 Lee MC, Bae SK, Lee MH, Chung JK, Koh CS, Roh JK, et al. Quantitative analysis of regional cerebral blood flow using $^99m$Tc-HMPAO SPECT in Parkinson's disease. Korean J Nucl Med 1992;26:251-6   과학기술학회마을
22 Colloby S, O'Brien J. Functional imaging in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17:158-63   DOI
23 Santens P, De Corte T, Vingerhoets G, Van Laere K, Dierckx R, De Reuck J. Regional cerebral blood flow and episodic memory in Parkinson's disease: a single photon emission tomography study. Eur Neurol 2003;49:238-42   DOI   ScienceOn
24 Samuel M, Ceballos-Baumann AO, Boecker H, Brooks DJ, Motor imagery in normal subjects and Parkinson's disease patients: an $H_2^{15}O$ PET study. Neuroreport 2001;26:821-8
25 Osaki Y, Morita Y, Fukumoto M, Akagi N, Yoshida S, Doi Y. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia. Mov Disord 2005;20:999-1005   DOI   ScienceOn
26 Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, et al. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin Neurol Neurosurg 2005;107:396-403   DOI   ScienceOn
27 고창순. 핵의학: 고려의학; 1997. p. 297-300
28 Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of $^99m$Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004;45:933-42
29 Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801   DOI   ScienceOn
30 Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology 1996;46:329-34   DOI
31 Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29-36   DOI   ScienceOn